Dronedarone Drug Profile
What is Dronedarone?
Dronedarone is a class III antiarrhythmic medication used to treat certain types of irregular heart rhythms. It belongs to the benzofuran class of antiarrhythmic drugs and is chemically related to amiodarone but with a different safety profile. Dronedarone is primarily prescribed to help maintain normal heart rhythm in patients with atrial fibrillation or atrial flutter who have returned to normal rhythm.
Uses
- Atrial fibrillation maintenance: Helps prevent the recurrence of atrial fibrillation in patients who have been successfully converted to normal heart rhythm
- Atrial flutter treatment: Used to maintain normal rhythm in patients with a history of atrial flutter
- Cardiovascular hospitalization reduction: May help reduce the risk of cardiovascular-related hospitalizations in certain patients with atrial fibrillation
- Heart rate control: Can help control heart rate in patients with paroxysmal atrial fibrillation
How it works
Dronedarone works by blocking multiple ion channels in heart muscle cells, including potassium, sodium, and calcium channels. This multi-channel blocking action helps stabilize the electrical activity of the heart and prevents the abnormal electrical signals that cause irregular heart rhythms. Unlike some other antiarrhythmic drugs, dronedarone also has mild beta-blocking and calcium channel blocking properties, which contribute to its effectiveness in maintaining normal heart rhythm.
Side effects
Common side effects:
- Diarrhea
- Nausea and vomiting
- Abdominal pain
- Fatigue and weakness
- Skin rash
- Bradycardia (slow heart rate)
- QT prolongation on ECG
- Increased serum creatinine levels
Serious side effects to watch for:
- Severe liver injury or hepatotoxicity
- Lung toxicity (pulmonary fibrosis)
- Heart failure worsening
- Severe bradycardia or heart block
- New or worsening arrhythmias
Warnings and precautions
- Heart failure contraindication: Dronedarone should not be used in patients with symptomatic heart failure or recent heart failure hospitalization, as it may increase mortality risk
- Permanent atrial fibrillation: Not recommended for patients with permanent atrial fibrillation who cannot be converted to normal rhythm
- Liver monitoring required: Regular liver function tests are necessary due to risk of hepatotoxicity; patients with severe liver impairment should avoid this medication
- Pregnancy and nursing: Should be avoided during pregnancy and breastfeeding unless benefits clearly outweigh risks
- Kidney function: May cause increases in serum creatinine; kidney function should be monitored regularly during treatment
Interactions
- Digoxin: Dronedarone increases digoxin levels significantly, requiring dose reduction and careful monitoring
- Warfarin and other anticoagulants: May increase bleeding risk by affecting anticoagulant metabolism
- Statins: Can increase statin levels, potentially leading to muscle toxicity
- CYP3A4 inhibitors (ketoconazole, clarithromycin): Increase dronedarone levels and toxicity risk
- Calcium channel blockers: May cause excessive heart rate slowing when used together
- Beta-blockers: Combined use may lead to severe bradycardia
- Grapefruit juice: Should be avoided as it can increase drug levels unpredictably
- St. John’s Wort: May reduce dronedarone effectiveness by increasing its metabolism
Check interactions with the GMJ Interaction Checker
Dosage
The typical adult dosage of dronedarone is 400 mg taken twice daily with morning and evening meals. The medication should always be taken with food to improve absorption and reduce gastrointestinal side effects. Dosage adjustments may be necessary in patients with kidney or liver problems, and some patients may require lower doses based on their response to treatment and tolerance of side effects. Healthcare providers will determine the appropriate dosage based on individual patient factors, including other medications, kidney and liver function, and overall health status.
Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.
Cite this page
GMJ News Desk. "Dronedarone." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/dronedarone/
This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).Was this article helpful?


